UBS Group’s inTEST INTT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $117K | Buy |
8,601
+8,123
| +1,699% | +$89.1K | ﹤0.01% | 6923 |
|
|
2025
Q4 | $3.57K | Sell |
478
-13,539
| -97% | -$107K | ﹤0.01% | 8993 |
|
|
2025
Q3 | $109K | Sell |
14,017
-9,532
| -40% | -$70K | ﹤0.01% | 7055 |
|
|
2025
Q2 | $171K | Buy |
23,549
+21,072
| +851% | +$134K | ﹤0.01% | 6824 |
|
|
2025
Q1 | $17.3K | Sell |
2,477
-2,149
| -46% | -$17.8K | ﹤0.01% | 8323 |
|
|
2024
Q4 | $39.7K | Buy |
4,626
+3,601
| +351% | +$27.3K | ﹤0.01% | 7443 |
|
|
2024
Q3 | $7.48K | Sell |
1,025
-8,173
| -89% | -$67.8K | ﹤0.01% | 7902 |
|
|
2024
Q2 | $90.9K | Sell |
9,198
-3,102
| -25% | -$33.2K | ﹤0.01% | 6239 |
|
|
2024
Q1 | $163K | Sell |
12,300
-2,951
| -19% | -$34.9K | ﹤0.01% | 5980 |
|
|
2023
Q4 | $207K | Buy |
15,251
+468
| +3% | +$6.21K | ﹤0.01% | 5759 |
|
|
2023
Q3 | $224K | Sell |
14,783
-5,476
| -27% | -$101K | ﹤0.01% | 5286 |
|
|
2023
Q2 | $532K | Buy |
20,259
+16,511
| +441% | +$364K | ﹤0.01% | 4769 |
|
|
2023
Q1 | $77.7K | Buy |
3,748
+829
| +28% | +$12.4K | ﹤0.01% | 6119 |
|
|
2022
Q4 | $30.1K | Buy |
2,919
+213
| +8% | +$1.98K | ﹤0.01% | 7242 |
|
|
2022
Q3 | $21K | Buy |
2,706
+776
| +40% | +$6.36K | ﹤0.01% | 7326 |
|
|
2022
Q2 | $13K | Buy |
1,930
+781
| +68% | +$6.17K | ﹤0.01% | 7513 |
|
|
2022
Q1 | $12K | Buy |
1,149
+359
| +45% | +$3.93K | ﹤0.01% | 8184 |
|
|
2021
Q4 | $10K | Buy |
+790
| New | +$10.2K | ﹤0.01% | 8779 |
|
|
2021
Q3 | – | Sell |
-4
| Closed | – | – | 9791 |
|
|
2021
Q2 | $0 | Sell |
4
-1,773
| -100% | -$23.9K | ﹤0.01% | 9575 |
|
|
2021
Q1 | $21K | Sell |
1,777
-547
| -24% | -$4.68K | ﹤0.01% | 7333 |
|
|
2020
Q4 | $15K | Buy |
2,324
+1,816
| +357% | +$9.23K | ﹤0.01% | 7162 |
|
|
2020
Q3 | $2K | Sell |
508
-1,192
| -70% | -$5.25K | ﹤0.01% | 7663 |
|
|
2020
Q2 | $6K | Buy |
1,700
+1,462
| +614% | +$4.65K | ﹤0.01% | 7297 |
|
|
2020
Q1 | $1K | Sell |
238
-2,613
| -92% | -$12.5K | ﹤0.01% | 7765 |
|
|
2019
Q4 | $17K | Buy |
2,851
+171
| +6% | +$900 | ﹤0.01% | 6989 |
|
|
2019
Q3 | $12K | Buy |
+2,680
| New | +$12K | ﹤0.01% | 7050 |
|
|
2019
Q2 | – | Sell |
-212
| Closed | -$1K | – | 7997 |
|
|
2019
Q1 | $1K | Buy |
212
+61
| +40% | +$439 | ﹤0.01% | 7546 |
|
|
2018
Q4 | $1K | Sell |
151
-926
| -86% | -$6.34K | ﹤0.01% | 7895 |
|
|
2018
Q3 | $8K | Buy |
+1,077
| New | +$8.71K | ﹤0.01% | 7277 |
|
|
2018
Q2 | – | Sell |
-1,380
| Closed | -$9K | – | 8103 |
|
|
2018
Q1 | $9K | Sell |
1,380
-653
| -32% | -$5.38K | ﹤0.01% | 6936 |
|
|
2017
Q4 | $18K | Buy |
+2,033
| New | +$18K | ﹤0.01% | 6627 |
|
|
2017
Q2 | – | Sell |
-2,026
| Closed | -$13K | – | 7804 |
|
|
2017
Q1 | $13K | Buy |
2,026
+1,645
| +432% | +$8.52K | ﹤0.01% | 6453 |
|
|
2016
Q4 | $2K | Sell |
381
-1,855
| -83% | -$7.75K | ﹤0.01% | 7508 |
|
|
2016
Q3 | $9K | Buy |
2,236
+516
| +30% | +$2.01K | ﹤0.01% | 6845 |
|
|
2016
Q2 | $7K | Buy |
+1,720
| New | +$6.71K | ﹤0.01% | 6973 |
|
|
2015
Q4 | – | Sell |
-1,649
| Closed | -$7K | – | 8456 |
|
|
2015
Q3 | $7K | Sell |
1,649
-2,589
| -61% | -$10.7K | ﹤0.01% | 7503 |
|
|
2015
Q2 | $18K | Buy |
4,238
+1,623
| +62% | +$7.34K | ﹤0.01% | 6971 |
|
|
2015
Q1 | $11K | Buy |
2,615
+1,299
| +99% | +$5.37K | ﹤0.01% | 7557 |
|
|
2014
Q4 | $6K | Buy |
+1,316
| New | +$5.75K | ﹤0.01% | 8832 |
|
Other funds holding INTT
RA
VCM
PRCP
CM
BA
UBS Group's INTT Position: Q1 2026 in Review
UBS Group increased its inTEST (INTT) stake by 1,699% in Q1 2026, buying an estimated $89.1K and bringing the position to 8,601 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #6923.
UBS Group first reported a position in INTT in Q4 2014 and has held it in 39 quarters since. The position peaked at $532K in Q2 2023. 75 funds tracked by Wall St. Rank hold INTT as of Q1 2026.
- UBS Group held 8,601 shares of inTEST worth $117K as of Q1 2026.
- UBS Group bought 8,123 inTEST shares in Q1 2026, an estimated $89.1K.
- inTEST made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6923 holding.
- UBS Group first reported a position in inTEST in Q4 2014 and has held it in 39 quarters since.
- UBS Group's inTEST position peaked at $532K in Q2 2023.
- 75 funds tracked by Wall St. Rank held inTEST as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.